RAS Inhibitors: Changing the Paradigm from the Undruggable.

Pharmaceutics · 2026 · PMC13415134 · PMID 42514855

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although no statistically significant overall survival benefit was observed—likely due to limited statistical power—a favorable trend in OS was noted in the combination arm, supporting its clinical relevance [ 86 ].

also in 1,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.